HIV I Infection

A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/

Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy

Evaluating the Safety and Immunogenicity of MTBVAC

To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments

Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretrovirals

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France

Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol

Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF

The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

Studying Topiramate for Re-Activating the HIV-1 Reservoir

The Visceral Adiposity Measurement and Observation Study

Acute Effects of TCIG vs ECIG in PLWH